Beyond radiation resistance, HFDs promote cancer cell survival through obesity-driven hyperinsulinemia and chronic inflammation, which activate oncogenic pro-survival pathways, including PI3K/AKT and STAT3. Here, AKT1 is linked to hyperinsulinism.